Preprint / Version 1

Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India

Authors

  • Debashish Kundu International Union Against Tuberculosis and Lung Disease (The Union), South-East Asia Office, C-6, Qutub Institutional Area, New Delhi, 110016 India
  • Nandini Sharma Department of Community Medicine, Maulana Azad Medical College, New Delhi, India
  • Sarabjit Chadha International Union Against Tuberculosis and Lung Disease (The Union), South-East Asia Office, C-6, Qutub Institutional Area, New Delhi, 110016 India
  • Samia Laokri Universite Libre de Bruxelles, Brussels, Belgium
  • George Awungafac African Society of Laboratory Medicine; Ministry of Health, Cameroon, Yaoundé, Cameroon
  • Lai Jiang Center for Instructional Psychology and Technology, Faculty of Psychology and Education Science, KU Leuven, Leuven, Belgium
  • Miqdad Asaria Global Health and Development, Imperial College London; Centre for Health Economics, University of York, York, United Kingdom

Keywords:

Multi-drug resistant tuberculosis, Health insurance, RSBY, Universal health coverage, Financial protection policy, Inequity, Kingdon’s multiple streams, Implementation, Poor, India

Abstract

Introduction There are significant financial barriers to access treatment for multi drug resistant tuberculosis (MDR-TB) in India. To address these challenges, Chhattisgarh state in India has established a MDR-TB financial protection policy by creating MDR-TB benefit packages as part of the universal health insurance scheme that the state has rolled out in their effort towards attaining Universal Health Coverage for all its residents. In these schemes the state purchases health insurance against set packages of services from third party health insurance agencies on behalf of all its residents. Provider payment reform by strategic purchasing through output based payments (lump sum fee is reimbursed as per the MDR-TB benefit package rates) to the providers – both public and private health facilities empanelled under the insurance scheme was the key intervention. Aim To understand the implementation gap between policy and practice of the benefit packages with respect to equity in utilization of package claims by the poor patients in public and private sector. Methods Data from primary health insurance claims from January 2013 to December 2015, were analysed using an extension of ‘Kingdon’s multiple streams for policy implementation framework’ to explain the implementation gap between policy and practice of the MDR-TB benefit packages. Results The total number of claims for MDR-TB benefit packages increased over the study period mainly from poor patients treated in public facilities, particularly for the pre-treatment evaluation and hospital stay packages. Variations and inequities in utilizing the packages were observed between poor and non-poor beneficiaries in public and private sector. Private providers participation in the new MDR-TB financial protection mechanism through the universal health insurance scheme was observed to be much lower than might be expected given their share of healthcare provision overall in India. Conclusion Our findings suggest that there may be an implementation gap due to weak coupling between the problem and the policy streams, reflecting weak coordination between state nodal agency and the state TB department. There is a pressing need to build strong institutional capacity of the public and private sector for improving service delivery to MDR-TB patients through this new health insurance mechanism. Keywords: Multi-drug resistant tuberculosis, Health insurance, RSBY, Universal health coverage, Financial protection policy, Inequity, Kingdon’s multiple streams, Implementation, Poor, India

Downloads